Alaunos Therapeutics, Inc. (TCRT:NASDAQ) closed at $3.04 on October 22, 2026, down 1.30% on the day. The stock trades 32.4% below its 52-week high of $4.50 and 322.2% above its 52-week low of $0.720. Over the past year, it gained 12.2%. Alaunos Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, TCRT closed higher on 104 days (41%). Its best day was October 13, 2026 (+188.57%) and its worst was October 14, 2026 (-31.68%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 3 times.
ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.
Find more stocks like TCRT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.